Nanjing Minova Pharmaceutical Co., Ltd.
Clinical trials sponsored by Nanjing Minova Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a single injection melt belly fat? a new trial aims to find out Results expected Feb 2027 (estimated)
-
Can a single injection melt belly fat? a new trial aims to find out
Disease control Recruiting nowThis early-stage trial is testing an investigational drug called MI226, given as a single injection into belly fat, to see if it is safe and tolerable. The study involves about 52 adults with noticeable abdominal fat accumulation. Researchers will monitor for side effects and how…
Phase 1 • Sponsor: Nanjing Minova Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Three-Day pill ease postpartum depression?
Disease control Recruiting nowThis phase 3 trial tests whether an experimental drug called MI078 can safely reduce symptoms of postpartum depression in new mothers. About 200 women aged 18 to 45 with a recent diagnosis of major depression linked to childbirth will receive either MI078 capsules or a placebo fo…
Phase 3 • Sponsor: Nanjing Minova Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC